EOM Pharmaceuticals Holdings, Inc., a clinical-stage biotechnology company, focuses on the development of drugs to transform therapeutic paradigms and enhance quality of life in patients suffering from debilitating and deadly diseases in the United States. The company's lead compound is EOM613, a...
9 insider purchases on record · latest filing 2015-12-02.
Insiders have also filed 19 sale transactions at IMUC.